Table 4.

Propensity score analysis for LFS, OS, RI, NRM, GRFS, aGVHD II–IV, aGVHD III–IV, cGVHD, and ext. cGVHD

	MUD	Haplo	p value
LFS	39.9% [34.7–45.1]	34.6% [27.9–41.3]	0.67
OS	42% [36.7–47.4]	38.7% [31.8–45.5]	0.33
RI	31.9% [27.2–36.7]	27.7% [21.7–34]	0.17
NRM	28.2% [23.6–32.9]	37.7% [31.1–44.3]	0.06
GRFS	24.8% [20.3–29.4]	30.2% [23.7–36.6]	0.15
aGVHD II-IV	33.1% [28.6–37.6]	30.5% [24.4–36.8]	0.28
cGVHD	40.6% [35.3–45.9]	26.5% [20.5–32.7]	0.24
ext cGVHD	20.5% [16.2–25.1]	10.7% [6.8–15.5]	0.041

Abbreviations: LFS, leukemia free survival; OS, overall survival; RI, relapse incidence; NRM, non-relapse mortality; GRFS, graft-versus-host-free-relapse free survival; a, acute; c, chronic; GVHD, graft versus host disease; ext., extensive